A phase 1/2 study of combination therapy of ivaltinostat, gemcitabine, and erlotinib in patients with unresectable, locally advanced and metastatic pancreatic adenocarcinomaJ. Jo,H. Lee, S. Park,D. Chung,S. Cho,H. Cha,J. Cho,S. SongANNALS OF ONCOLOGY（2020）引用 1|浏览143暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
